Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model

被引:0
|
作者
Kuriko Kagitani-Shimono
Ikuko Mohri
Yasushi Fujitani
Kinuko Suzuki
Keiichi Ozono
Yoshihiro Urade
Masako Taniike
机构
[1] Osaka University Graduate School of Medicine,Department of Developmental Medicine (Pediatrics)
[2] Osaka Bioscience Institute,Department of Molecular Behavioral Biology
[3] University of North Carolina at Chapel Hill,Department of Pathology and Laboratory Medicine
关键词
Glial Fibrillary Acidic Protein; Glatiramer Acetate; Phosphodiesterase Inhibitor; Experimental Allergic Encephalomyelitis; Cerebellar White Matter;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] PREVENTION OF AUTOIMMUNE DEMYELINATION IN NONHUMAN-PRIMATES BY A CAMP-SPECIFIC PHOSPHODIESTERASE INHIBITOR
    GENAIN, CP
    ROBERTS, T
    DAVIS, RL
    NGUYEN, MH
    UCCELLI, A
    FAULDS, D
    LI, Y
    HEDGPETH, J
    HAUSER, SL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) : 3601 - 3605
  • [22] ASYMPTOMATIC CNS DEMYELINATION RELATED TO TNF-α INHIBITOR THERAPY
    Ali, Farwa
    Laughlin, Ruple S.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2017, 4 (01):
  • [23] Anti-cd20 therapy prevents cortical demyelination in a new rat model
    Haindl, M. T.
    Ucal, M.
    Togl, L.
    Klaus, B.
    Dohrmann, J.
    Adzemovic, M.
    Enzinger, C.
    Hochmeister, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 564 - 565
  • [24] Engraftment, migration, and differentiation of genetically modified neural stem cells in the Twitcher model of progressive demyelination.
    Taylor, RM
    McCarthy, N
    Snyder, EY
    EXPERIMENTAL NEUROLOGY, 2002, 175 (02) : 434 - 434
  • [25] Clinical features of demyelination following anti-TNFα therapy
    Hendy, P.
    Heerasing, N.
    Walker, G.
    Heap, G.
    Bewshae, C.
    Kennedy, N.
    Goodhand, J.
    Martin, R.
    Hobart, J.
    Harrower, T.
    Coles, A.
    Ahmad, T.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S360 - S360
  • [26] CLINICAL FEATURES OF DEMYELINATION FOLLOWING ANTI-TNFA THERAPY
    Hendy, Peter
    Heerasing, Neel
    Walker, Gareth
    Goodhand, James
    Harrower, Tim
    Hobart, Jeremy
    Spiers, Alexander
    Coles, Alasdair
    Martin, Roswell
    Ahmad, Tariq
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A47 - A47
  • [27] Demyelination After Anti-TNF Therapy: Who is at Risk?
    Williams, Isabelle
    Uhlig, Holm H.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (12): : 1651 - 1652
  • [28] Demyelination during anti-TNFα therapy for ankylosing spondylitis
    Mercieca, Cecilia
    Vella, Norbert
    Borg, Andrew A.
    MODERN RHEUMATOLOGY, 2012, 22 (02) : 303 - 307
  • [29] The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson's disease
    Schwenkgrub, Joanna
    Zaremba, Malgorzata
    Joniec-Maciejak, Ilona
    Cudna, Agnieszka
    Mirowska-Guzel, Dagmara
    Kurkowska-Jastrzebska, Iwona
    PLOS ONE, 2017, 12 (07):
  • [30] PERIPHERAL INFLAMMATORY STIMULUS EXACERBATE THE ONGOING CENTRAL DAMAGE IN AN INFLAMMATORY MODEL OF DEMYELINATION
    Ferrari, C.
    Murta, V
    Pitossi, F.
    GLIA, 2011, 59 : S137 - S137